Product Information
JOLESSA 0.15 MG-0.03 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2267 per EA under NDC 00555912366. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 5, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555912366
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA021544FDA Approved
9/5/2003
TE Code
AB
On Market Since
10/13/2003
Price Statistics
The NADAC for JOLESSA 0.15 MG-0.03 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 76.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2267 per EA |
|---|---|
| All-time high | $0.9955 (Apr 13, 2016) |
| All-time low | $0.1058 (Nov 20, 2024) |
| 52-week high | $0.2267 |
| 52-week low | $0.1515 |
| Median price | $0.2959 |
| Average price | $0.4252 |
| Largest weekly change | +55.0% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levonorgestrel / Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel / Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JOLESSA 0.15 MG-0.03 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JOLESSA 0.15 MG-0.03 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2267 per EA (NDC 00555912366), effective Sep 30, 2026.
How has the price of JOLESSA 0.15 MG-0.03 MG TABLET changed over time?
Over the history we have for it, the NADAC for JOLESSA 0.15 MG-0.03 MG TABLET has declined 76.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for JOLESSA 0.15 MG-0.03 MG TABLET?
Since Nov 28, 2013, the NADAC for JOLESSA 0.15 MG-0.03 MG TABLET has ranged from a low of $0.1058 (Nov 20, 2024) to a high of $0.9955 (Apr 13, 2016), with a median of $0.2959 per EA.
Are there cheaper alternatives to JOLESSA 0.15 MG-0.03 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of JOLESSA 0.15 MG-0.03 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures JOLESSA 0.15 MG-0.03 MG TABLET?
JOLESSA 0.15 MG-0.03 MG TABLET (NDC 00555912366) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.